Literature DB >> 26823149

Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.

Olga Ciccarelli1, Alan Thompson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26823149     DOI： 10.1038/nrneurol.2016.2

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

Review 1.  Progressive MS: from pathophysiology to drug discovery.

Authors:  Marco Salvetti; Douglas Landsman; Peter Schwarz-Lam; Giancarlo Comi; Alan J Thompson; Robert J Fox
Journal:  Mult Scler       Date:  2015-09-11       Impact factor: 6.312

2.  Long-term assessment of no evidence of disease activity in relapsing-remitting MS.

Authors:  Nicola De Stefano; Maria Laura Stromillo; Antonio Giorgio; Marco Battaglini; Maria Letizia Bartolozzi; Maria Pia Amato; Maria Pia Sormani
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

3.  Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

Authors:  Mar Tintore; Àlex Rovira; Jordi Río; Susana Otero-Romero; Georgina Arrambide; Carmen Tur; Manuel Comabella; Carlos Nos; María Jesús Arévalo; Laura Negrotto; Ingrid Galán; Angela Vidal-Jordana; Joaquin Castilló; Filipe Palavra; Eva Simon; Raquel Mitjana; Cristina Auger; Jaume Sastre-Garriga; Xavier Montalban
Journal:  Brain       Date:  2015-04-21       Impact factor: 13.501

4.  Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

Authors:  Tomas Kalincik; Dana Horakova; Tim Spelman; Vilija Jokubaitis; Maria Trojano; Alessandra Lugaresi; Guillermo Izquierdo; Csilla Rozsa; Pierre Grammond; Raed Alroughani; Pierre Duquette; Marc Girard; Eugenio Pucci; Jeannette Lechner-Scott; Mark Slee; Ricardo Fernandez-Bolanos; Francois Grand'Maison; Raymond Hupperts; Freek Verheul; Suzanne Hodgkinson; Celia Oreja-Guevara; Daniele Spitaleri; Michael Barnett; Murat Terzi; Roberto Bergamaschi; Pamela McCombe; Jose Sanchez-Menoyo; Magdolna Simo; Tunde Csepany; Gabor Rum; Cavit Boz; Eva Havrdova; Helmut Butzkueven
Journal:  Ann Neurol       Date:  2015-01-17       Impact factor: 10.422

5.  The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study.

Authors:  Léorah Freeman; Daniel Garcia-Lorenzo; Laure Bottin; Claire Leroy; Céline Louapre; Benedetta Bodini; Caroline Papeix; Rana Assouad; Benjamin Granger; Ayman Tourbah; Frédéric Dollé; Catherine Lubetzki; Michel Bottlaender; Bruno Stankoff
Journal:  Ann Neurol       Date:  2015-08-21       Impact factor: 10.422

6.  Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T.

Authors:  Céline Louapre; Sindhuja T Govindarajan; Costanza Giannì; Christian Langkammer; Jacob A Sloane; Revere P Kinkel; Caterina Mainero
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

7.  Comorbidity delays diagnosis and increases disability at diagnosis in MS.

Authors:  R A Marrie; R Horwitz; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal:  Neurology       Date:  2008-10-29       Impact factor: 9.910

8.  Effect of comorbidity on mortality in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Stella Leung; Nancy Yu
Journal:  Neurology       Date:  2015-05-27       Impact factor: 9.910

Review 9.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

Review 10.  Risk evaluation and monitoring in multiple sclerosis therapeutics.

Authors:  Michel C Clanet; Jerry S Wolinsky; Raymond J Ashton; Hans-Peter Hartung; Stephen C Reingold
Journal:  Mult Scler       Date:  2013-11-30       Impact factor: 6.312
  10 in total
  3 in total

1.  MiR-30a Positively Regulates the Inflammatory Response of Microglia in Experimental Autoimmune Encephalomyelitis.

Authors:  Xue Fang; Dingya Sun; Zhihong Wang; Zhongwang Yu; Weili Liu; Yingyan Pu; Dan Wang; Aijun Huang; Mingdong Liu; Zhenghua Xiang; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2017-07-17       Impact factor: 5.203

2.  Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.

Authors:  Reas S Khan; Kimberly Dine; Bailey Bauman; Michael Lorentsen; Lisa Lin; Helayna Brown; Leah R Hanson; Aleta L Svitak; Howard Wessel; Larry Brown; Kenneth S Shindler
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

3.  Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy.

Authors:  Jörn Lötsch; Susanne Schiffmann; Katja Schmitz; Robert Brunkhorst; Florian Lerch; Nerea Ferreiros; Sabine Wicker; Irmgard Tegeder; Gerd Geisslinger; Alfred Ultsch
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.